Novavax Asks FDA To Authorize Its Non-mRNA Covid Vaccine
Topline
Novavax on Monday asked the U.S. Food and Drug Administration to grant emergency use authorization to its Covid-19 vaccine, which relies on traditional protein-based technology…
Read More...
Read More...